About CMS Ventures
CMS Ventures is a venture capital firm founded in 2019. It is primarily based out of Cambridge, United Kingdom. As of Aug 2025, CMS Ventures has invested in 13 companies. It primarily invests in Seed round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Blockchain Technology to High Tech and FinTech. Most recently it participated in the $***** Series A round of BOB Overall, CMS Ventures portfolio has seen 2 IPOs and 1 acquisition, namely Astrazeneca, China Medical System and CC Bio. A lot of funds co-invest with CMS Ventures, with names like Spartan Group sharing a substantial percentage of its portfolio. CMS Ventures has team of 5 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio IPOs
Portfolio Acquisitions
CMS Ventures' List of Top Investments
CMS Ventures has a portfolio of 13 companies. Their most notable investments are in Minterest and Qureight.Their portfolio spans across United Kingdom, China, United States and 4 more locations. They have invested in Blockchain Technology, High Tech, FinTech and 7 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by CMS Ventures:1. Astrazeneca
AstraZeneca is a British-Swedish multinational pharmaceutical and biologics company. It is the world's seventh-largest pharmaceutical company measured by 2012 prescription drug sales (after Pfizer, Sanofi, Novartis, Merck Co., Roche, and GlaxoSmithKline) and has operations in over 100 countries. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. The company was founded in 1999 through the merger of the Sweden-based Astra AB and the UK-based Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). It has made numerous corporate acquisitions, including of Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). In 2022, the company recorded annual revenues of $43.85B and a net profit of $4.73B.
Key facts about Astrazeneca
- Founded Year: 1913
- Location: Cambridge (United Kingdom)
- Annual Revenue: 34.6M HRK as on Dec 31, 2020
- Stage: Public
- Employee Count: 83,100 as on Dec 31, 2021
- Investors: Digital Pharma Lab, Investor and 12 Others
- Latest Funding Round: Post IPO, Dec 27, 2021, $*****
- Highlight: Public
2. BOB
Blockchain infrastructure platform for Bitcoin development. It offers a platform that allows users to build on Bitcoin by combining Bitcoin's security and stability with the EVM and the OP stack. It supports the Bitcoin ecosystem, Bitcoin smart contract SDK, and more.
Key facts about BOB
- Founded Year: 2023
- Location: George Town (Cayman Islands)
- Stage: Series A
- Total Funding till date: $21.1M
- Investors: BlackRock, Cathay Capital and 27 Others
- Latest Funding Round: Series A, Aug 07, 2025, $*****
- Highlight: Editors' Pick
3. Qureight
AI enabled data curation platform for drug development. It specializing in AI-powered data and imaging curation to advance understanding of lung and heart diseases, accelerating drug development through clinical trials, new endpoints, and synthetic control arms.
Key facts about Qureight
- Founded Year: 2018
- Location: Cambridge (United Kingdom)
- Stage: Series A
- Total Funding till date: $11.2M
- Employee Count: 14 as on Jul 01, 2024
- Investors: Playfair Capital, Playfair Capital and 18 Others
- Latest Funding Round: Series A, Apr 16, 2024, $*****
- Highlight: Editors' Pick
China Medical System manufactures generic formulations. They offer tablets, capsules, liquids, and injectables. The products are of various therapeutic categories including cardiovascular, respiratory, oncology, analgesics, CNS, etc. They have also pipeline products. Their lead molecule FP-1201 is used for Acute Respiratory Distress Syndrome, which is in phase III clinical trial.
Key facts about China Medical System
- Founded Year: 1992
- Location: Shenzhen (China)
- Stage: Public
- Investors: CMS Ventures
- Highlight: Public
5. Pendle
Provider of blockchain-enabled financial protocol for trading tokens. It enables the trading of tokenized future yield on an AMM system. It supports multiple protocols and assets for the management of yield on a single platform. Transactions are verified & handled by smart contracts.
Key facts about Pendle
- Founded Year: 2020
- Location: Remote (United States)
- Stage: Series A
- Total Funding till date: $3.5M
- Employee Count: 14 as on Jul 01, 2024
- Investors: Skycatcher, Signum Capital and 19 Others
- Latest Funding Round: Series A, Nov 10, 2023, $*****
CMS Ventures' Year-on-Year Investment Trends
CMS Ventures has invested in 13 companies over the last 5 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 1 investment. Its most recent first time investment was in BOB and most recent follow-on round was in BOB.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
2023 | 0 | 0 | 0 |
2022 | 3 | 0 | 3 |
2021 | 6 | 0 | 6 |
CMS Ventures' Investments by Stage
CMS Ventures has made 6 investments in Seed stage with an average round size of $3.73M and 4 investments in Series A stage with an average round size of $8M.Stage of entry | No. of Investments |
|---|---|
Seed | 6 |
Series A | 4 |
Note: We have considered here, only first round of investments
CMS Ventures' Investments by Sector
CMS Ventures has a diverse portfolio, with companies operating in the Blockchain - Industry Applications, Blockchain Technology, FinTech, High Tech and Enterprise Applications. Notably, it has invested in 11 Tech companies, 8 Blockchain companies, 8 Enterprise (B2B) companies and at least 7 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Blockchain - Industry Applications | 8 |
Blockchain Technology | 8 |
FinTech | 8 |
High Tech | 6 |
Enterprise Applications | 3 |
Others | 6 |
Note: We have considered here, only first round of investments
CMS Ventures' Investments by Geography
CMS Ventures has made most investments in United Kingdom (3), followed by United States where it has made 2 investments.Country | No. of Investments |
|---|---|
United Kingdom | 3 |
United States | 2 |
Cayman Islands | 1 |
China | 1 |
Estonia | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
CMS Ventures' recent investments
CMS Ventures has not made any investment in 2026 so far.Here are the most recent investments by CMS Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Aug 07, 2025 | Cayman Islands | Series A | 4153 | [+10] | |
Mar 27, 2024 | Cayman Islands | Seed | 5145 | ||
Sep 16, 2022 | United Kingdom | Seed | 6788 | [+5] | |
Jun 02, 2022 | Switzerland | Seed | 9693 | [+2] | |
Feb 24, 2022 | United States | Series A | 8750 | [+12] |
IPOs and Publicly Listed companies in CMS Ventures' Portfolio
2 of CMS Ventures' portfolio companies have become public. China Medical System got listed on the Hong Kong Exchanges (HKG), in Sep 2010 and Astrazeneca got listed on the New York Stock Exchange (NYSE).Here are CMS Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 28, 2010 | - | - | 7810 | |
May 12, 1993 | - | - | 7429 |
Acquired companies in CMS Ventures' Portfolio
1 company from CMS Ventures' portfolio has been acquired. The most recent acquisition was CC Bio in Mar 2024 by PrecisioBiotix for $*****.Here are CMS Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 01, 2024 | Aug 26, 2021 | Seed | 8138 |
Team profile of CMS Ventures
CMS Ventures has a team of 5 members including 4 Partners located in United Kingdom and United States. CMS Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in CMS Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Menlo Park | - | - | |
Partner | Cambridge | - | - | |
Partner | United Kingdom | - | - | |
Partner | - | - | - |
Co-investors of CMS Ventures
Over the past 5 years, 125 investors have co-invested in CMS Ventures's portfolio companies. This includes funds and angels.
- Invested before CMS Ventures: Standard Crypto, DRAGONFLY and 11 others have invested in rounds before CMS Ventures. There is 1 company where Standard Crypto has invested before CMS Ventures and 1 company where DRAGONFLY has invested before CMS Ventures.
- Top Co-investors of CMS Ventures: 74 investors entered a company along with CMS Ventures. These include investors like Spartan Group (3 companies).
- Invested after CMS Ventures: A total of 38 investors have invested in CMS Ventures's portfolio after their investments. Top Investors include Ledger (1 company), BlackRock (1 company) and Rarible (1 company).
Recent News related to CMS Ventures
•
Hamilton Raises USD 1.7M in a Pre-Seed Funding Round - WAYAWAYA Media•Jan 20, 2025•Hamilton, DisrupTech, Core Ventures, Hamilton Treasury and 6 others
•
UTXO Stack Completes Series A Funding, Plans TGE in Q1 2025Cryptopotato•Dec 19, 2024•UTXO Stack, Utxo Management, Paka Capital, ABCDE and 10 others
•
Bitcoin network infrastructure developer Satflow completes $7.6 million financing, led by VariantCoinTime•Aug 15, 2024•Satflow, Variant Fund, Nascent, Utxo Management and 10 others
•
Qureight secures Series A funding to accelerate drug developmentPharmaceutical Technology•Apr 16, 2024•Qureight, Hargreave Hale VCTs, XTX Markets, Meltwind Advisory and 5 others
•
Zeus Network Raises Over $8M in FundingFinSMEs•Apr 15, 2024•The Zeus Network, Mechanism Capital, OKX, Castle Island Ventures and 31 others
•
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEAACN Newswire•Jan 02, 2024•China Medical System, Rxilient, Pharmaron, HealthifyMe and 1 other
•
Infinity Exchange lands $4.2M to accelerate institutional DeFi adoption and create the next trillion-dollar marketTechStartups.com•Sep 16, 2022•Infinity Exchange, GSR Ventures, SIG Venture Capital, CMS Ventures and 2 others
•
Slope Finance announces the close of an $8m Series A funding co-lead by Solana Venture and Jump CapitalGlobeNewswire•Feb 24, 2022•Slope, Solana Ventures, Jump Capital, HongShan and 11 others
•
Phantasia Raises $1.85 Million to Launch Fantasy Sports on SolanaGlobeNewswire•Nov 02, 2021•Phantasia, Sino Global Capital, GSR, Shamrao Vithal Co-operative Bank and 7 others
•
New Indie Blockchain Game Publisher Ex Populus Announces $3M Seed Round Led by Animoca BrandsBusiness Wire•Oct 28, 2021•Ex Populus, Animoca Brands, CMS Ventures, Enjin and 5 others
